Cramer expects BioCryst's stock to jump whenever avian flu gets mentioned in the media, he said. At that point, you should sell it. If in six months nothing has happened and no one is talking about avian flu, you should sell it then, too, he said.
Also, don't pay up for the stock, he advised. Try to buy it at least within 50 cents or so of where the stock closed the regular trading session Monday at $12.98, said Cramer.
Cramer is changing his tune on oil tanker shipping company
. Cramer has been bearish on GMR "for 20 points down," he said. But, rates for midsized oil tankers are up 20% to 30% so far in October in the wake of hurricanes Katrina and Rita, and GRM is the pure play on midsized oil tankers, with the world's second largest midsized tanker fleet, he said.
Cramer also mentioned
, which has the world's largest fleet of midsized oil tankers. But Teekay also owns one large-class oil tanker, and rates for the largest class of tankers have declined 50% vs. last year's average and are not recovering strongly, said Cramer.
"General Maritime's rates are recovering," said Cramer. "The rest of the tanker business is sitting dead in the water ... You go with GMR."
Allscripts Healthcare Solutions'
(MDRX - Get Report)
CEO Glen Tullman spoke with Cramer on the phone. Cramer asked Tullman how close doctors are to having fully computerized offices.
Tullman said the trend is just beginning. "It's turned for the big physician groups, and it's starting to turn in the mid-market," he said.
Cramer asked why Allscripts' solutions were better than competitors' offerings such those from
, "another company I like a lot," said Cramer.
Tullman said Allscripts' product is easier to install and use and that Allscripts has a built-in advantage in the high-end market because of its relationship with practice-management software provider,